Cathy Burgess will present during this program organized by FDANews. The program will look back at recent developments and what we can expect from the FDA in 2024 considering the regulatory and political environment. They will discuss some of the FDA’s 2024 priorities what new programs and policies will be initiated, and how companies need to plan and adjust.
For more information, click here.